You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline

A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News' Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, and CBS News researcher Max Bayer has more on the FDA hearing.
image beaconimage beaconimage beacon